We are live on ! Find out more
CP

Camelot Portfolios Portfolio holdings

AUM $143M
1-Year Est. Return 14.82%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+14.82%
3 Year Est. Return
+41.29%
5 Year Est. Return
+33.84%
10 Year Est. Return
+115.32%
AUM
$135M
AUM Growth
+$28.9M
Cap. Flow
+$22.5M
Cap. Flow %
16.67%
Top 10 Hldgs %
24.35%
Holding
206
New
45
Increased
71
Reduced
54
Closed
29

Sector Composition

Rank Sector Weight
1 Financials 7.21%
2 Consumer Discretionary 6.35%
3 Real Estate 6.12%
4 Industrials 5.21%
5 Technology 4.99%

Similar funds

Camelot Portfolios's Q4 2022 Portfolio in Review

As of Q4 2022, Camelot Portfolios held 206 positions worth $135M, up 27% from $106M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Camelot Portfolios deployed $22.5M of net new capital in Q4 2022, opening 45 new positions and adding to 71 existing holdings. Its largest new stake was Invesco BulletShares 2024 Corporate Bond ETF: 246,067 shares worth $5.04M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, up from 6.5% a quarter earlier, followed by Consumer Discretionary and Real Estate.

On the sell side, the largest reduction was Vanguard Morningstar Small-Cap ETF, an estimated $623K trimmed.

  • Camelot Portfolios's largest Q4 2022 buy was Invesco BulletShares 2024 Corporate Bond ETF: 246,067 shares worth $5.04M.
  • Camelot Portfolios added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2022, an estimated $3.51M increase.
  • Camelot Portfolios's biggest Q4 2022 reduction was Vanguard Morningstar Small-Cap ETF, cutting an estimated $623K.
  • Camelot Portfolios fully exited Sabra Healthcare REIT in Q4 2022, selling an estimated $855K.
  • Camelot Portfolios's ten largest holdings make up 24% of its $135M portfolio in Q4 2022.
  • Camelot Portfolios opened 45 new positions and closed 29 in Q4 2022.
  • Camelot Portfolios's portfolio value rose 27% quarter-over-quarter to $135M.

Based on Camelot Portfolios's 13F filing for Q4 2022, filed 25 Jan 2023.